XML 31 R45.htm IDEA: XBRL DOCUMENT v2.4.0.6
Business Combinations and Divestitures (Details)
 3 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended 6 Months Ended
Jul. 01, 2012
USD ($)
Jul. 03, 2011
USD ($)
Jul. 01, 2012
USD ($)
Jul. 03, 2011
USD ($)
Apr. 01, 2012
Bystolic [Member]
USD ($)
Jul. 01, 2012
Synthes, Inc [Member]
USD ($)
Jul. 03, 2011
Synthes, Inc [Member]
USD ($)
Jul. 01, 2012
Synthes, Inc [Member]
USD ($)
years
Jul. 03, 2011
Synthes, Inc [Member]
USD ($)
Jun. 14, 2012
Synthes, Inc [Member]
USD ($)
Jun. 14, 2012
Synthes, Inc [Member]
CHF
Jul. 01, 2012
Crucell .N. V [Member]
USD ($)
Jul. 03, 2011
Crucell .N. V [Member]
USD ($)
Business Acquisition [Line Items]                          
Business Acquisition, Cost of Acquired Entity, Cash Paid                   $ 6,902,000,000 [1]      
Aquirees Common Stock Outstanding                   118,700,000 118,700,000    
Business Combination, Recognized Identifiable Intangible Assets Acquired [Abstract]                          
Customer relationships           9,950,000,000   9,950,000,000          
Patents and technology           1,495,000,000   1,495,000,000          
Total amortizable intangibles           11,445,000,000   11,445,000,000         700,000,000
Trademark and Trade name           1,420,000,000   1,420,000,000          
In-process research and development           64,000,000   64,000,000          
Business Acquisition, Purchase Price Allocation [Abstract]                          
Cash and Cash equivalents           2,749,000,000   2,749,000,000   2,749,000,000      
Inventory           889,000,000 [2]   889,000,000 [2]          
Accounts Receivable, net           738,000,000   738,000,000          
Other current assets           249,000,000   249,000,000          
Property, plant and equipment           1,253,000,000   1,253,000,000          
Goodwill           5,371,000,000   5,371,000,000         500,000,000
Intangible assets           12,929,000,000   12,929,000,000          
Other non-current assets           46,000,000   46,000,000          
Total Assets Acquired           24,224,000,000   24,224,000,000          
Current liabilities           825,000,000   825,000,000          
Deferred Taxes           2,731,000,000   2,731,000,000          
Other non-current liabilities           431,000,000   431,000,000          
Total Liabilities Assumed           3,987,000,000   3,987,000,000          
Net Assets Acquired           20,237,000,000   20,237,000,000          
Intangible asset write-downs     1,368,000,000 160,000,000               500,000,000  
Exchange rate used for acquisition           0.95674   0.95674     55.65    
Share exchanged for acquirees stock                   1.717 1.717    
Business Acquisition, Initial Consideration Transferred                   19,700,000,000      
Business Acquisition, Pro Forma Information [Abstract]                          
Net Sales           17,410,000,000 17,524,000,000 34,481,000,000 34,609,000,000        
Net Earnings           1,631,000,000 2,772,000,000 5,641,000,000 6,108,000,000        
Diluted Net Earnings per Common Share           $ 0.58 $ 1.00 $ 2.02 $ 2.20        
Business Combinations and Divestitures (Textuals) [Abstract]                          
Business Acquisition, Cost of Acquired Entity, Transaction Costs           457,000,000   457,000,000          
Business Combination, Consideration Transferred                   20,200,000,000      
Discount Rate Used in Probability of Success in Research and Development               14.00%          
Proceeds from Divestiture of Businesses         357,000,000                
Business Acquisition, Cost of Acquired Entity, Purchase Price                         2,000,000,000
Business Acquisition, Purchase Price Allocation, Intangible Assets Not Amortizable                         1,000,000,000
Stock Issued During Period, Value, Acquisitions           13,335,000,000 [3]              
Stock Repurchased During Period, Value           203,700,000              
Accelerated Share Repurchases, Settlement Payment or Receipt 12,900,000,000   12,900,000,000                    
Incremental common shares attributable to accelerated share repurchase agreements 13,200,000 0 13,200,000 0                  
Acquired Finite-lived Intangible Asset, Weighted Average Useful Life               21          
Finite-Lived Intangible Assets, Useful Life, Minimum               7          
Finite-Lived Intangible Assets, Useful Life, Maximum               22          
Total 16,475,000,000 16,597,000,000 32,614,000,000 32,770,000,000   193,000,000              
Net earnings 1,408,000,000 2,776,000,000 5,318,000,000 6,252,000,000   28,000,000              
Payments to Acquire Businesses, Net of Cash Acquired     17,659,000,000 2,049,000,000       17,500,000,000          
Common Stock Share Price                   65.45      
Research and Development in process impairment charge $ 429,000,000 $ 0 $ 429,000,000 $ 0               $ 429,000,000  
[1] Synthes common stock outstanding of 118.7 million shares as of the acquisition date and CHF/USD exchange rate of .95674
[2] Includes $0.4 billion related to inventory step-up.
[3] Johnson & Johnson closing stock price on the New York Stock Exchange as of acquisition date of $65.45 per share.